LCT and autoimmune polyendocrinopathy: According to the 2023 ACR/EULAR antiphospholipid syndrome (APS) classification criteria [8], the patient meets the clinical criteria based on venous thromboembolism and the laboratory criteria with persistent LAC positivity, supporting a diagnosis of APS.